Skip to main content

Table 1. Epidemiological and clinical characterization of the patients enrolled in the study

From: Deregulation of IL-37 and its miRNAs modulators in sarcopenic patients after rehabilitation

Sarcopenic patients T0 T1 p-value
21 21  
Gender (M:F) 8:13  
Age (years) 73.2 ± 8.9  
Education (years) 8.2 ± 3.13  
MMSE 28.8 ± 1.13 28.5 ± 2.27
CDT 3.40 ± 1.51 4.19 ± 0.84 0.0026
Yesavage GDS 8.14 ± 5.67 7.34 ± 5.85 0.04
CCI 3.61 ± 1.41
KATZ 2.88 ± 1.31 5.33 ± 0.67 0.0001
I.A.D.L (LAWTON-Brody instrumental activity) 2.89 ± 0.32 3.44 ± 1.05 0,0084
  1. Data are expressed as mean ± standard deviation
  2. Statistical analysis were performed using Wilcoxon test (paired samples); p-value (p) < 0.05 were considered statistically significant
  3. MMSE: Mini-Mental State Examination; CDT: Clock Drawing test; GDS: Geriatric Depression Scale; CCI: Charlson Comorbidity Index